The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090

By AHRMM

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

Related Resources

Podcasts
Hear from Myla Maloney, Vice President, Strategy and Commercial Operations at Premier as she teaches the four value-based contracting methods suppl
Educational Podcast
Listen as Bruce Radcliff, System VP of Supplier Diversity at Advocate Aurora Health discusses the tangible methods to build supplier diversity base
e-Learning
This advanced course leads learners through 10 areas of infrastructure surrounding the functions of health care supply chain management.
Podcasts
Listen as Elizabeth Hilla, Senior Vice President, Health Industry Distributors Association (HIDA), discusses the most successful strategic sourcing